Luminera
Luminera, founded in 2012 and based in Lod, Israel, is a leading company in the aesthetics industry, known for its innovative dermal filler products. The company's product portfolio includes HArmonyCa, a unique dermal filler combining cross-linked hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) microspheres for facial soft tissue augmentation. Other popular products in their lineup include Crystalys and Hydryalix, which are recognized for their high safety and effectiveness. In 2020, Luminera was acquired by Allergan Aesthetics, an AbbVie company, enhancing Allergan's already robust dermal filler portfolio. This acquisition has allowed for further development and distribution of Luminera's innovative products in international markets, including the US. Luminera's commitment to quality and innovation is evident in their continuous research and development efforts, aiming to provide advanced solutions for facial rejuvenation and contouring. The company's products are trusted by aesthetic professionals worldwide, making them a preferred choice for high-quality aesthetic treatments.
Luminera Introduction
Luminera is a manufacturer and R&D company for injectable medical devices in the aesthetic medicine field. The company was founded in 2013 in Israel but was acquired by Allergan Aesthetics in 2020. Luminera operates strictly under the highest regulatory standards in compliance with local and international directives. It pays close attention to product conformity along with supplying quality products. The company’s portfolio includes a complete line of injectable dermal fillers such as Crystalys, Hydryalix, Hydryal, and the new dermal filler HArmoneyCa.